The future of Alzheimer’s research may depend on a question that sounds simple but is proving difficult to answer: does the same prevention approach work the same way for everyone?
A 2022 study examining individualized Alzheimer’s risk management found that women showed greater improvement than men in several risk measures, while cognitive outcomes were more complicated.
The findings offer a closer look at how researchers are studying personal differences in Alzheimer’s prevention at a time when women represent about two-thirds of people living with the disease.
The most revealing part of the study is not a competition between women and men, but what it suggests about the future of personalized Alzheimer’s research.
The Study Behind the Headline
A closer look at the research shows a study about individual responses, not a simple winner and loser.
The 2022 study, published in The Journal of Prevention of Alzheimer’s Disease, analyzed data from the Comparative Effectiveness Dementia and Alzheimer’s Registry (CEDAR). Researchers wanted to understand whether sex influenced how people responded to individualized clinical management of Alzheimer’s risk.
The program used personal health information to guide recommendations. Participants received guidance based on clinical assessments, cognitive testing, blood biomarkers, genetic information, and lifestyle factors.
The approach included exercise, diet, sleep, stress reduction, cognitive engagement, vascular risk reduction, medical management, education, and genetic counseling. Rather than applying one standard plan to everyone, researchers examined how personalized recommendations affected different participants.
The sex difference analysis, however, was narrower than some headlines may suggest. It focused on a higher compliance subgroup of 80 participants who followed more than 60 percent of recommendations, while the broader CEDAR cohort included 154 participants.
The Results Were More Complicated Than the Headline
The study found differences in certain risk measures, while cognitive outcomes depended on the group being studied.
Researchers examined cognitive outcomes alongside Alzheimer’s and cardiovascular risk indicators. In the Prevention group, both women and men showed cognitive improvement, and researchers found no significant difference between the sexes in that measure.
For participants in the Early Treatment group, cognitive improvements were not statistically significant for either women or men.
The differences that drew attention appeared in specific risk measurements. Women showed greater improvement in MESA cardiovascular risk scores in the Prevention group.
Among participants in the Early Treatment group, women showed greater improvement in both MESA cardiovascular risk scores and CAIDE dementia risk scores.
Blood markers including glucose, LDL cholesterol, and HbA1C also improved more in women, mainly within the Early Treatment group.
Save this article
Enter your email address and we'll send it straight to your inbox.
The findings did not establish that women universally benefit more from Alzheimer’s prevention efforts. They showed that, within this study, some measurements changed differently between women and men.
The Question Hidden Inside the Data
The study’s most important contribution may be the question it raises about how personalized care could shape Alzheimer’s research.
Richard S. Isaacson, M.D., the study’s lead author, described the findings as evidence that individualized care improved cognitive function in both women and men. In contrast, women showed greater improvement in certain risk scales and blood biomarkers.
“While care in an Alzheimer’s Prevention Clinic setting is equally effective at improving cognitive function in both women and men, our personally tailored interventions led to greater improvements in women compared to men across Alzheimer’s and cardiovascular disease risk scales, as well blood biomarkers of risk such as blood sugar, LDL cholesterol, and the diabetes test HbA1C.”
The statement reflects the study’s central finding, but the details matter. The differences were linked to specific measurements and participant groups, not every outcome across the entire study.
What Scientists Still Do Not Know
The research found differences, but it did not explain why they occurred or prove that the intervention prevented Alzheimer’s disease.
The study measured cognitive performance, risk scores, and biomarkers. It did not demonstrate that participants avoided developing Alzheimer’s disease because of the intervention.
Researchers also did not determine why women improved more in some areas. The study did not confirm whether biological differences, lifestyle patterns, or other factors explained the results.
The authors emphasized that larger studies are needed to better understand sex differences in Alzheimer’s-related cognitive changes and prevention strategies.
The Bigger Shift In Alzheimer’s Prevention
The study reflects a broader move in research toward understanding why the same health approach may affect different people in different ways.
For years, Alzheimer’s prevention discussions have focused on familiar recommendations such as exercise, diet, sleep, and managing health risks. This research examines a more specific question: whether individual characteristics can help explain prevention strategies.
The findings do not provide a final answer about how Alzheimer’s prevention should work for everyone. They add another piece of evidence to an ongoing effort to understand how personalized approaches might fit into future research.
The headline may have started with a comparison between women and men, but the broader question remains. As scientists continue studying personalized approaches, the challenge may be learning not only what helps protect the brain, but how to shape those strategies around the people receiving them.
Could the next phase of Alzheimer’s prevention depend on understanding not just what works, but who responds best to each approach?
